These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19562501)

  • 21. Retinal Deposits in a Young Woman.
    Oliver R; Sallam AB; Uwaydat SH
    JAMA Ophthalmol; 2018 Jun; 136(6):708-709. PubMed ID: 29522126
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1.
    Machaczka M; Klimkowska M
    Ann Hematol; 2014 Oct; 93(10):1787-9. PubMed ID: 24577513
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1?
    Matta MC; Vairo F; Torres LC; Schwartz I
    Blood Cells Mol Dis; 2018 Feb; 68():200-202. PubMed ID: 28029576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease.
    Braudeau C; Graveleau J; Rimbert M; Néel A; Hamidou M; Grosbois B; Besançon A; Giraudet S; Terrien C; Josien R; Masseau A
    Blood Cells Mol Dis; 2013 Apr; 50(4):281-8. PubMed ID: 23357793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competing for the treasure in exceptions.
    Cox TM
    Am J Hematol; 2013 Mar; 88(3):163-5. PubMed ID: 23400870
    [No Abstract]   [Full Text] [Related]  

  • 27. Home treatment with enzyme replacement therapy in a 5-year-old girl with type 2 Gaucher disease.
    Migita M; Shimada T; Hayakawa J; Zhi CL; Morita T; Ohshiro K; Fukunaga Y
    Pediatr Int; 2003 Jun; 45(3):363-5. PubMed ID: 12828600
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
    J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease.
    Limgala RP; Jani C; Ioanou C; Alpan O; Goker-Alpan O
    Blood Cells Mol Dis; 2018 Feb; 68():81-85. PubMed ID: 27839980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.
    Giuffrida G; Markovic U; Condorelli A; Duminuco A; Calafiore V; Conticello C; Romano A; Grasso S; Riccobene C; Ragusa MTV; Esposito B; Nicolosi D; Calagna M; Nardo A; Consoli U; Uccello G; Di Giacomo V; Neri S; Cingari MR; Rodà F; Innao V; Fiumara A; Duro G; Zizzo C; Di Raimondo F
    Eur J Haematol; 2023 Dec; 111(6):922-929. PubMed ID: 37747757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme replacement therapy in a child with Gaucher disease.
    Masood Y; Ali AS
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):786-8. PubMed ID: 17125641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
    Rosenbloom BE; Cappellini MD; Weinreb NJ; Dragosky M; Revel-Vilk S; Batista JL; Sekulic D; Mistry PK
    Am J Hematol; 2022 Oct; 97(10):1337-1347. PubMed ID: 36054609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
    Mistry PK; Deegan P; Vellodi A; Cole JA; Yeh M; Weinreb NJ
    Br J Haematol; 2009 Nov; 147(4):561-70. PubMed ID: 19732054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hemorrhage in type 3 Gaucher disease: a case report.
    Vellodi A; Ashworth M; Finnegan N; Wallis C
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S329-31. PubMed ID: 20689991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful desensitization to imiglucerase of an adult patient diagnosed with type I Gaucher disease.
    Erdoğdu D; Gelincik A; Canbaz B; Colakoğlu B; Büyüköztürk S; Tanakol R
    Int Arch Allergy Immunol; 2013; 160(2):215-7. PubMed ID: 23018845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once again, rare diseases provide a spotlight.
    Lal TR; Borger DK; Sidransky E
    Mol Genet Metab; 2016 May; 118(1):1-2. PubMed ID: 27017192
    [No Abstract]   [Full Text] [Related]  

  • 39. Switching from imiglucerase to miglustat for the treatment of French patients with Gaucher disease type 1: a case series.
    Serratrice C; Swiader L; Serratrice J
    J Med Case Rep; 2015 Jun; 9():146. PubMed ID: 26100396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease.
    Andrade-Campos MM; de Frutos LL; Cebolla JJ; Serrano-Gonzalo I; Medrano-Engay B; Roca-Espiau M; Gomez-Barrera B; Pérez-Heredia J; Iniguez D; Giraldo P
    Orphanet J Rare Dis; 2020 Sep; 15(1):256. PubMed ID: 32962737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.